Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 11378339

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2001 Jun
First author
Gortzak E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Gortzak E
      type
      Author
    2. name
      Azzarelli A
      type
      Author
    3. name
      Buesa J
      type
      Author
    4. name
      Bramwell VH
      type
      Author
    5. name
      van Coevorden F
      type
      Author
    6. name
      van Geel AN
      type
      Author
    7. name
      Ezzat A
      type
      Author
    8. name
      Santoro A
      type
      Author
    9. name
      Oosterhuis JW
      type
      Author
    10. name
      van Glabbeke M
      type
      Author
    11. name
      Kirkpatrick A
      type
      Author
    12. name
      Verweij J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Gortzak E
      type
      Author
    2. name
      Azzarelli A
      type
      Author
    3. name
      Buesa J
      type
      Author
    4. name
      Bramwell VH
      type
      Author
    5. name
      van Coevorden F
      type
      Author
    6. name
      van Geel AN
      type
      Author
    7. name
      Ezzat A
      type
      Author
    8. name
      Santoro A
      type
      Author
    9. name
      Oosterhuis JW
      type
      Author
    10. name
      van Glabbeke M
      type
      Author
    11. name
      Kirkpatrick A
      type
      Author
    12. name
      Verweij J
      type
      Author
    bibliography ids
    1. nci-bib-385a6eaf91cb28ca2501aa0c
    book metadata
    content sha256
    0a852b6302737a391c246d059fb5cf2eb815541aaf7a54280d0ba22aeb29fa32
    document type
    citation
    dois
    1. 10.1016/s0959-8049(01)00083-1
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11378339
    immutable id
    pubmed:11378339@0a852b6302737a391c246d059fb5cf2eb815541aaf7a54280d0ba22aeb29fa32
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    Source null
    issn print
    0959-8049
    issue
    9
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    1096-103
    volume
    37
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11378339
      provenance
      batch id
      30d2cd7affbbb92b6784
      provider
      NCBI PubMed ESummary
      record sha256
      a3e86fe2f2d5ea03caf116fe9f8b722c6e7e290666e03db925ae9f6820afdb06
      response sha256
      ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
      retrieved at
      2026-09-09T23:45:39.779418+00:00
      publication date
      display
      2001 Jun
      precision
      month
      year
      2001
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Clinical Trial, Phase III
      4. Journal Article
      5. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11378339/
      title
      A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.

      Preserved source evidence · Not medical advice